Zhang Zhenfei, Wu Fang, Zhou Zejie, Luo Huixian, Qin Yuehua, Yang Meng, Mo Yinjuan, Zhu Zhiqiang, Zhang Yi, Guo Yonghui
Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue Central, Guangzhou, 510280, P. R. China.
Guangdong Provincial Clinical Research Center for Laboratory Medicine, 253 Industrial Avenue Central, Guangzhou, 510280, P. R. China.
BMC Cardiovasc Disord. 2025 Jan 6;25(1):3. doi: 10.1186/s12872-024-04398-6.
To establish the reference intervals of plasma Plasminogen, Factor XII activity, and Factor XIII Antigen in healthy adults in Guangzhou.
A total of 168 young people (75 males and 93 females, aged 18-65 years) who underwent physical examination in Zhujiang Hospital of Southern Medical University from 2020 to 2022 were recruited. Sysmex CS5100 automatic coagulation analyzer and matching reagents were used to detect Plasminogen. Factor XII activity and Factor XIII Antigen were detected using the ACL TOP 700 (Instrumentation Laboratory, Bedford, MA, USA) automatic coagulation analyzer and matching reagents; reference intervals were established.
Plasma Plasminogen and Factor XIII Antigen were normally distributed, and plasma Factor XII activity showed a skewed distribution with no statistical significance in gender. The established reference intervals were as follows: Plasminogen: 71.6-123.0%; Factor XIII Antigen: 55.1-113.1%; Factor XII: 42.3-144.1%.
The reference intervals for special coagulation items of the laboratory population in a particular area should be established to provide results that align with the population characteristics for assessing the coagulation status of clinical patients.
建立广州地区健康成年人血浆纤溶酶原、凝血因子Ⅻ活性及凝血因子ⅩⅢ抗原的参考区间。
选取2020年至2022年在南方医科大学珠江医院进行体检的168名年轻人(男性75名,女性93名,年龄18 - 65岁)。采用Sysmex CS5100全自动凝血分析仪及配套试剂检测纤溶酶原。使用ACL TOP 700(美国马萨诸塞州贝德福德市仪器实验室公司)全自动凝血分析仪及配套试剂检测凝血因子Ⅻ活性和凝血因子ⅩⅢ抗原;建立参考区间。
血浆纤溶酶原和凝血因子ⅩⅢ抗原呈正态分布,血浆凝血因子Ⅻ活性呈偏态分布,性别间无统计学意义。建立的参考区间如下:纤溶酶原:71.6 - 123.0%;凝血因子ⅩⅢ抗原:55.1 - 113.1%;凝血因子Ⅻ:42.3 - 144.1%。
应建立特定地区实验室人群特殊凝血项目的参考区间,以提供与人群特征相符的结果,用于评估临床患者的凝血状态。